Harry L. Messmore
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 1%
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
Papers in
-
- Venous Thromboembolism Diagnosis and Management 44
- Hematology 49
- Platelet Disorders and Treatments 20
- Blood Coagulation and Thrombosis Mechanisms 18
- Co-authors
- Jawed FareedJeanine M. WalengaWalter JeskeSucha NandWilliam H. WehrmacherDebra HoppensteadtEdward W. BermesDebra A. Hoppensteadt
- Journals
- Seminars in Thrombosis and Hemostasis (17 papers)Thrombosis Research (7 papers)Thrombosis and Haemostasis (6 papers)JAMA (4 papers)Annals of the New York Academy of Sciences (3 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Harry L. Messmore
118 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 114
- Internal Medicine 761
- Hematology 817
- Emergency Medicine 274
- Cardiology and Cardiovascular Medicine 592
- Genetics 209
Countries citing papers authored by Harry L. Messmore
This map shows the geographic impact of Harry L. Messmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry L. Messmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry L. Messmore more than expected).
Fields of papers citing papers by Harry L. Messmore
This network shows the impact of papers produced by Harry L. Messmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry L. Messmore. The network helps show where Harry L. Messmore may publish in the future.
Co-authors
The 25 scholars most cited alongside Harry L. Messmore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 8 | |
| 2 | 2005 | 91 | |
| 3 | 2005 | 1 | |
| 4 | 2004 | 37 | |
| 5 | 2004 | 2 | |
| 6 | 2004 | 8 | |
| 7 | 2002 | 1 | |
| 8 | 1999 | 5 | |
| 9 | 1993 | 9 | |
| 10 | 1992 | 22 | |
| 11 | 1992 | 18 | |
| 12 | 1991 | 10 | |
| 13 | 1990 | 67 | |
| 14 | 1990 | 43 | |
| 15 | 1990 | 53 | |
| 16 | 1989 | 2 | |
| 17 | 1989 | 52 | |
| 18 | 1986 | 8 | |
| 19 | Sinus histiocytosis with massive lymphadenopathy: remission with chemotherapy. | 1983 | 17 |
| 20 | Zinc prevention of lead induced inhibition of human blood delta aminolevulinic acid dehydratase (ALAD) activity in vitro | 1976 | 1 |
About Harry L. Messmore
Harry L. Messmore is a scholar working on Internal Medicine, Hematology, Emergency Medicine, Genetics and Surgery, having authored 125 papers that have together received 2.2k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (44 papers), Heparin-Induced Thrombocytopenia and Thrombosis (44 papers), Platelet Disorders and Treatments (20 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers), Intramuscular injections and effects (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Atrial Fibrillation Management and Outcomes (10 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). The work is most often cited by research in Internal Medicine (761 citations), Hematology (817 citations), Emergency Medicine (274 citations), Cardiology and Cardiovascular Medicine (592 citations) and Genetics (209 citations). Harry L. Messmore has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Jawed Fareed, Jeanine M. Walenga, Walter Jeske, Sucha Nand, William H. Wehrmacher, Debra Hoppensteadt, Edward W. Bermes, Debra A. Hoppensteadt, Richard I. Fisher and Sarfraz Ahmad. Their work appears in journals such as Seminars in Thrombosis and Hemostasis, Thrombosis Research, Thrombosis and Haemostasis, JAMA and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.